Hot
Description
Comprehensive Hematology & Medical Oncology Board Review (6-Day)
High-Yield • ABIM Hem/Onc • Exam-Focused
This 6-day comprehensive review covers current standards and practices in managing patients with blood disorders and malignancy. It is designed to help participants effectively prepare for the American Board of Internal Medicine (ABIM) Hematology and Medical Oncology certification and recertification examinations. The curriculum integrates advances in clinical pharmacology, molecular genetics & risk assessment, and radiation oncology.
| Duration | 6-Day Intensive Review |
|---|---|
| Exam Alignment | Mapped to ABIM Hematology & Medical Oncology blueprints |
| Scope | Standards of care, pharmacology, molecular genetics, risk assessment, radiation oncology |
Learning Objectives
- Apply new knowledge to prepare for ABIM Hematology & Medical Oncology certification and recertification exams.
- Utilize current standards of care for patients with cancer and blood disorders.
- Demonstrate proficiency across core domains of hematology and medical oncology.
- Incorporate recent advances into the management of hematologic and oncologic patients.
Access & Delivery
Program content is exam-focused and structured for efficient review. Delivery format and CME/MOC availability depend on the original provider; please refer to official registration details for credits and logistics.
Related Courses
💎 Enjoy a 15% permanent discount when you purchase any two or more courses together — no limits, always active.
Frequently Asked Questions
How closely does the course follow the ABIM Hematology/Oncology blueprints?
The syllabus is aligned with ABIM exam domains to reinforce high-yield topics, test-taking strategies, and clinical decision-making.
Is this primarily exam prep or also practical for everyday practice?
Both. While exam-focused, sessions emphasize current standards of care and recent advances that translate into daily clinical workflows.
Are updates in pharmacology, molecular genetics, and radiation oncology included?
Yes. The 6-day format incorporates advances in clinical pharmacology, molecular genetics/risk assessment, and radiation oncology as part of the core update.
Does this course provide CME/MOC credit?
Credit availability depends on the original provider and registration pathway. Please check the official provider page for CME/MOC specifics.
